Spots Global Cancer Trial Database for hematopoietic cell transplant
Every month we try and update this database with for hematopoietic cell transplant cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Safety and Efficacy of BL-8040 for the Mobilization of Donor Hematopoietic Stem Cells and Allogeneic Transplantation in Patients With Advanced Hematological Malignancies | NCT02639559 | Acute Myelogeno... Acute Lymphobla... Chronic Myeloge... Non-Hodgkin's L... Non-Hodgkin Lym... Hodgkin Disease Hodgkins Diseas... Hodgkin's Disea... Multiple Myelom... Myelodysplastic... Myeloproliferat... | BL-8040 Leukapheresis Hematopoietic c... | 18 Years - 75 Years | Washington University School of Medicine | |
| A Study of the Drug Letermovir (LTV) as Prevention for Recurrent of Cytomegalovirus (CMV) Infection | NCT04017962 | CMV CMV Infection Hematopoietic C... | Letermovir Pill blood draw | 12 Years - | Memorial Sloan Kettering Cancer Center | |
| Study of ProTmune for Allogeneic HCT in Adult Patients With Hematologic Malignancies | NCT02743351 | Hematologic Mal... Acute Myeloid L... Acute Lymphobla... Myelodysplastic... Chronic Myeloge... Acute Graft-ver... | ProTmune Control Arm | 18 Years - | Fate Therapeutics | |
| Phase I/II Trial: Engineered Donor Graft (Orca Q) for Pediatric Hematopoietic Cell Transplant (HCT) | NCT05322850 | Acute Myeloid L... Acute Lymphoid ... Mixed Phenotype... Acute Undiffere... Chronic Myeloid... Chronic Myeloid... Chronic Myeloid... | Orca-Q | - 50 Years | University of Florida | |
| Cognitive Training Intervention and Attitudes Towards Genetics | NCT03094026 | Cognitive Impai... Hematologic Neo... Hematopoietic C... | Lumosity Lumosity (waitl... | 21 Years - | University of Alabama at Birmingham | |
| A Study of Whether Ide-cel (bb2121) Can Be Made From People With Multiple Myeloma Who Have Had a Hematopoietic Cell Transplant | NCT05393804 | Multiple Myelom... | Ide-cel (bb2121... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| A Study of the Drug Letermovir (LTV) as Prevention for Recurrent of Cytomegalovirus (CMV) Infection | NCT04017962 | CMV CMV Infection Hematopoietic C... | Letermovir Pill blood draw | 12 Years - | Memorial Sloan Kettering Cancer Center | |
| Evaluating Immune Response to COVID-19 Vaccines in Patients With Cancer, Transplant or Cellular Therapy Recipients | NCT05164016 | Cancer Hematopoietic S... Transplant-Rela... Solid Tumor Mal... Hematologic Mal... Solid Organ Tra... Hematopoietic C... Cellular Therap... | - 24 Years | St. Jude Children's Research Hospital | ||
| Trial of Allogeneic Reduced-Intensity, HLA-Haploidentical Bone Marrow Transplantation Followed by Graft-versus-Host-Disease (GVHD) Prophylaxis With Cyclophosphamide, Bortezomib and Maraviroc for Hematologic Malignancies in People Living With HIV | NCT05470491 | HIV Hematologic Mal... | RIC GVHD prophylaxi... allo HCT Plerixafor Maraviroc | 12 Years - 120 Years | National Institutes of Health Clinical Center (CC) | |
| Evaluating Immune Response to COVID-19 Vaccines in Patients With Cancer, Transplant or Cellular Therapy Recipients | NCT05164016 | Cancer Hematopoietic S... Transplant-Rela... Solid Tumor Mal... Hematologic Mal... Solid Organ Tra... Hematopoietic C... Cellular Therap... | - 24 Years | St. Jude Children's Research Hospital | ||
| Blood Samples to Identify Biomarkers of Busulfan | NCT02291965 | Leukemia Lymphoma Multiple Myelom... Immunodeficienc... Myelodysplastic... | - | Fred Hutchinson Cancer Center | ||
| Phase I/II Trial: Engineered Donor Graft (Orca Q) for Pediatric Hematopoietic Cell Transplant (HCT) | NCT05322850 | Acute Myeloid L... Acute Lymphoid ... Mixed Phenotype... Acute Undiffere... Chronic Myeloid... Chronic Myeloid... Chronic Myeloid... | Orca-Q | - 50 Years | University of Florida | |
| Donor Natural Killer Cells and Aldesleukin in Treating Patients w/High Risk AML Undergoing Donor Stem Cell Transplant | NCT00303667 | Acute Myelogeno... | aldesleukin natural killer ... cyclophosphamid... fludarabine pho... allogeneic hema... total body irra... Thymoglobulin Cyclosporin A cyclophosphamid... fludarabine pho... | 18 Years - 70 Years | Masonic Cancer Center, University of Minnesota | |
| T-Cell Replete Haploidentical Donor Hematopoietic Stem Cell Plus Natural Killer (NK) Cell Transplantation in Patients With Hematologic Malignancies Relapsed or Refractory Despite Previous Allogeneic Transplant | NCT01621477 | Acute Lymphobla... Acute Myelocyti... Chronic Myelocy... Juvenile Myelom... Myelodysplastic... Hodgkin or Non-... Sarcoma, Myeloi... | clofarabine cytarabine busulfan Plerixafor cyclophosphamid... antithymocyte g... stem cells Tacrolimus mycophenolate m... | - 21 Years | St. Jude Children's Research Hospital | |
| Cytomegalovirus (CMV) Vaccine in Donors and Recipients Undergoing Allogeneic Hematopoietic Cell Transplant (HCT) | NCT00285259 | Acute Lymphobla... Chronic Myeloge... Acute Myelogeno... Hodgkin's Lymph... Non-Hodgkin's L... Myelodysplastic... | VCL-CB01 Phosphate-buffe... | 18 Years - 65 Years | Astellas Pharma Inc | |
| Blood Samples to Identify Biomarkers of Busulfan | NCT02291965 | Leukemia Lymphoma Multiple Myelom... Immunodeficienc... Myelodysplastic... | - | Fred Hutchinson Cancer Center | ||
| Donor Natural Killer Cells and Aldesleukin in Treating Patients w/High Risk AML Undergoing Donor Stem Cell Transplant | NCT00303667 | Acute Myelogeno... | aldesleukin natural killer ... cyclophosphamid... fludarabine pho... allogeneic hema... total body irra... Thymoglobulin Cyclosporin A cyclophosphamid... fludarabine pho... | 18 Years - 70 Years | Masonic Cancer Center, University of Minnesota | |
| A Study of Whether Ide-cel (bb2121) Can Be Made From People With Multiple Myeloma Who Have Had a Hematopoietic Cell Transplant | NCT05393804 | Multiple Myelom... | Ide-cel (bb2121... | 18 Years - | Memorial Sloan Kettering Cancer Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
